Standard or Convalescent Plasma in Patients With Recent Onset of COVID-19 Respiratory Failure
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
Thymosin Alpha 1 to Prevent COVID-19 Infection in Renal Dialysis Patients
- Status
- COMPLETED
- Phase
- PHASE2
Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise
- Status
- RECRUITING
- Phase
- PHASE2
A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population
- Status
- COMPLETED
- Phase
- N/A
Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19
- Status
- UNKNOWN
- Phase
- N/A
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )
- Status
- TERMINATED
- Phase
- PHASE2
Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study
- Status
- UNKNOWN
- Phase
- N/A
COVID-19 Antibodies Among Healthcare Workers
- Status
- COMPLETED
- Phase
- N/A
Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）
- Status
- UNKNOWN
- Phase
- NA
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19
- Status
- TERMINATED
- Phase
- PHASE3
A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).
- Status
- COMPLETED
- Phase
- PHASE2
A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19
- Status
- UNKNOWN
- Phase
- PHASE3
Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
COVID-19 Lessons Learned: the Outcome of TOMEKA® Project is to Teach
- Status
- UNKNOWN
- Phase
- N/A
Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients
- Status
- UNKNOWN
- Phase
- N/A